Cancer Communications
indexed by SCI

About the cover
About the cover

Dec. 2016; Volume 35 Issue 12

1, On December 19, 1978, cisplatin, the "penicillin of cancer drugs", was approved for use in testicular and ovarian cancers by the U.S. Food and Drug Administration.

2, In December 1942, nitrogen mustards started to be used as an effective treatment for cancer for the treatment of lymphoma in human clinical trials, which is the beginning of the modern era of cancer chemotherapy.

Research Highlight
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Elizabeth A. Kuczynski and Robert S. Kerbel
[ Abstract  840]  [ PDF Full-text  989]   [ HTML Full-text  366]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0162-7
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Shaodong Hong and Li Zhang
[ Abstract  681]  [ PDF Full-text  1089]   [ HTML Full-text  594]    Epub: 2016-12-23  doi: 10.1186/s40880-016-0163-6
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
Ilaria Fuso Nerini, Marta Cesca, Francesca Bizzaro and Raffaella Giavazzi
[ Abstract  833]  [ PDF Full-text  1013]   [ HTML Full-text  944]    Epub: 2016-6-29  doi: 10.1186/s40880-016-0123-1
Defeating cancer: the 150 most important questions in cancer research and clinical oncology
Chao-Nan Qian, Wei Zhang and Rui-Hua Xu
[ Abstract  599]  [ PDF Full-text  893]   [ HTML Full-text  637]    Epub: 2016-12-30  doi: 10.1186/s40880-016-0165-4
Original Article
Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment
Wenhua Liang, Guanzhu Shen, Yaxiong Zhang, Gang Chen, Xuan Wu, Yang Li, Anchuan Li, Shiyang Kang, Xi Yuan, Xue Hou, Peiyu Huang, Yan Huang, Hongyun Zhao, Ying Tian, Chong Zhao and Li Zhang
[ Abstract  852]  [ PDF Full-text  995]   [ HTML Full-text  362]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0160-9
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
Run-Fen Cheng, Jian Wang, Jing-Yi Zhang, Lin Sun, Yan-Rui Zhao, Zhi-Qiang Qiu, Bao-Cun Sun and Yan Sun
[ Abstract  1172]  [ PDF Full-text  1807]   [ HTML Full-text  1089]    Epub: 2016-7-2  doi: 10.1186/s40880-016-0128-9
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
Yan-Ping Mao, Ling-Long Tang, Lei Chen, Ying Sun, Zhen-Yu Qi, Guan-Qun Zhou, Li-Zhi Liu, Li Li, Ai-Hua Lin and Jun Ma
[ Abstract  599]  [ PDF Full-text  994]   [ HTML Full-text  606]    Epub: 2016-12-30  doi: 10.1186/s40880-016-0167-2
The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis
John Zeng Hong Li, Wei Gao, Wai-Kuen Ho, Wen Bin Lei, William Ignace Wei, Jimmy Yu-Wai Chan and Thian-Sze Wong
[ Abstract  689]  [ PDF Full-text  811]   [ HTML Full-text  661]    Epub: 2016-11-20  doi: 10.1186/s40880-016-0158-3
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
Yun Leng, Lugui Qiu, Jian Hou, Yaozhong Zhao, Xuejun Zhang, Shifang Yang, Hao Xi, Zhongxia Huang, Ling Pan and Wenming Chen
[ Abstract  794]  [ PDF Full-text  926]   [ HTML Full-text  793]    Epub: 2016-9-8  doi: 10.1186/s40880-016-0140-0
Original Article
ABO blood group is a predictor of survival in patients with laryngeal cancer
Ting Jin, Pei-Jing Li, Xiao-Zhong Chen and Wei-Han Hu
[ Abstract  716]  [ PDF Full-text  877]   [ HTML Full-text  720]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0152-9
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin and Zhong-Jun Xia
[ Abstract  764]  [ PDF Full-text  1288]   [ HTML Full-text  770]    Epub: 2016-9-13  doi: 10.1186/s40880-016-0150-y
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
Yu-Xiang He, Ying Wang, Peng-Fei Cao, Lin Shen, Ya-Jie Zhao, Zi-Jian Zhang, Deng-Ming Chen, Tu-Bao Yang, Xin-Qiong Huang, Zhou Qin, You-Yi Dai and Liang-Fang Shen
[ Abstract  799]  [ PDF Full-text  1391]   [ HTML Full-text  672]    Epub: 2016-11-17  doi: 10.1186/s40880-016-0159-2
Study Protocol
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E. Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto and Tae Won Kim
[ Abstract  710]  [ PDF Full-text  1225]   [ HTML Full-text  599]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0166-3
Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma
Lin Kong, Jing Gao, Jiyi Hu, Weixu Hu, Xiyin Guan, Rong Lu and Jiade J. Lu
[ Abstract  744]  [ PDF Full-text  892]   [ HTML Full-text  604]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0164-5

CC Wechat 微信公众号


Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China